Wockhardt UK’s product packaging design helps to enhance patient safety
The drive to improve patient safety is vitally important to the NHS. With this in mind - over recent years - we have enhanced the packaging design of our generic product range, based on extensive research with our customers and in collaboration with NHS recommendations.
The key patient safety features to our packaging include:
- Clear font style and large font sizes
- Carefully chosen colours to differentiate between product ranges and strengths
- Route of administration (the way the medication is taken), clearly displayed on the front of the pack
- Duplication on the product labels where applicable.
Market-leading innovation - TALL MAN lettering
Wockhardt UK was the first pharmaceutical company in the UK to use “Tall Man” lettering on product packaging. It was initially introduced on our cephalosporin injection range and was then also applied to our other look-alike and sound-alike products. Tall Man lettering involves highlighting part of the drug's name on the product packaging and labelling. For example, cefotaxime and ceftazidime are written as cefotaxime and ceftazidime, which helps to distinguish between look-alike and sound-alike product names. Tall Man Lettering clearly identifies and highlights the different parts of the product names which may cause confusion.
The aim of using Tall Man lettering is to reduce the risk of product mis-selection by both healthcare proffessionals and patients.
At Wockhardt UK, we are constantly looking at new and innovative ways to improve our product packaging, so if you do have any suggestions, then please do not hesitate to contact us. We value your opinion and all reasonable suggestions will be considered.
Old CP Pharmaceuticals livery
Wockhardt UK packaging design incorporating Tall Man lettering